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1. Introduction 
The Hazardous Substances Advisory Committee (HSAC) provides expert advice to UK officials, Ministers 
and other relevant bodies on the protection of the environment, and human health via the environment, from 
potentially hazardous substances and articles1. The Committee’s membership is multi-disciplinary and 
independent, enabling it to approach the evidence from a range of different perspectives. The Code of 
Practice requires members to observe the highest standards of impartiality, integrity and objectivity in 
relation to the advice they provide; the Code also includes clear provisions for handling conflicts of interest. 
Hazardous substances are often the subject of controversy, on which individuals, and different groups in 
society, hold divergent views. In formulating its advice, the Committee needs to analyse, interpret and assess 
the available evidence, often in situations where the uncertainties may be considerable. This paper 
documents the different kinds of evidence that might be available to the Committee; the criteria that HSAC 
adopts in its assessments; and the wider perspectives and concerns that have a bearing on the issues at hand. 
It also proposes a process through which the Committee’s judgements about the quality of the available 
evidence could be communicated in an accessible form. 
2. Types of evidence 
HSAC recognises that evidence varies in its source, robustness and defensibility, and that these factors will 
influence the degree of confidence that assessors can assign to any given ‘piece’ of evidence, or to a body of 
evidence as a whole. While most of the scientific evidence assessed by HSAC derives from experimental or 
epidemiological studies, or is based on modelling of some kind, observational and anecdotal evidence may 
also be considered (Table 1). Evidence in the last two categories sometimes provides a first indication that a 
phenomenon is worthy of further investigation, and can lead to more systematic studies.  It is likely that the 
availability of less systematic evidence will increase with the evolution of social media. Statistical evidence 
is often grounded on hypotheses which have been tested to a certain degree.  However, it takes time and 
resources to collect statistically robust data, so that such studies may not reflect rapidly changing 
circumstances and emerging problems. 
                                                     
1 The HSAC Terms of Reference and its Code of practice can be downloaded from 
https://www.gov.uk/government/groups/hazardous-substances-advisory-committee  
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Table 1.  Categories of evidence 
  
Type of evidence 
Experimental Model-based Epidemiological Observational Anecdotal 
 
Obtained through a 
methodological 
approach to 
experimental design 
and data collection.  
 
Possible to show 
causality/association 
 
Computer modelling 
of effects or 
exposures to provide 
a measurement of 
impact.  
 
Infers causality 
Data based on studies 
of populations under 
real-world conditions.  
 
 
 
Infers association 
 
Based on 
observations and 
experience.  
 
 
 
 
Infers association 
 
Based on personal 
accounts of effects. 
 
 
 
 
Hypothetical 
association - 
potentially identifies 
issues of concern, not 
yet addressed in 
scientific research 
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Repeated 
experiments with a 
high degree of 
replication and 
controls 
 following  
internationally 
accepted  standards 
(e.g. OECD Test 
Guidance 
Documents) 
 
 
 
Approach informed 
by empirical 
evidence, all 
processes and 
parameters revealed 
to allow repetition 
by others  
Follows published 
guidance (e.g. WHO) 
with clear methods 
and rationale for data 
inclusion or exclusion 
 
Field observations 
made in a systematic 
way, but without a 
specific 
experimental design 
 
Relatively high 
incidence of specific 
effects; consistency 
between unconnected 
accounts; different 
accounts carefully 
collated. 
Not meeting widely-
accepted 
experimental 
protocols; untested 
method, poorly 
reported 
Model without 
antecedents, 
parameters from 
assumptions not 
measurements, 
processes a black 
box, i.e. cannot be 
repeated by others  
Un-tested method, 
inadequately 
reported, using non-
standard 
measurements of 
impact 
 
Circumstantial 
evidence random or 
‘one off’ events or 
phenomena 
Uncorroborated, 
unconfirmed 
anecdotes: ‘a friend of 
a friend…’ 
 
There can be significant variations of quality within each type of evidence. Examples (not exhaustive) are given of 
what might be considered ‘high’ or ‘low’ quality evidence within each column; in practice, there will be a 
gradation. No simple (horizontal) quality continuum between different types of evidence is implied; see sections 3 
and 4 below. 
3. Judging quality: considerations to take into account 
In reviewing the scientific evidence, HSAC considers the extent to which any given study meets the 
following, widely-accepted criteria. HSAC may attach particular weight to evidence that conforms to these 
criteria, though ‘weaker’ evidence (in these terms) should not be dismissed: it can be part of the bigger 
picture when different sources of evidence are combined. 
 Transparency of aims. A study should have a clearly stated purpose, in terms of the problem to which 
it relates and the research questions to be addressed. Conventionally, this is achieved through the 
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statement of a hypothesis.  The hypothesis to be tested should preferably link to previous work, and the 
study should be clear about the ways in which it builds upon, or challenges, the evidence base. The 
nature of HSAC’s work is such that the Committee is often focusing on substances that have not been 
subject to exhaustive scientific studies (nanomaterials would be one example). In this case the 
hypothesis may be that a suspected causal agent is responsible for harm and it is important to recognize 
that this is essentially an arbitrary formulation. In assessing the stated hypothesis, it has to be clearly 
structured so that it is properly testable and falsifiable. HSAC recognises that findings based on 
statistical evidence are conditional on the structure of the hypotheses, and also on a potentially arbitrary 
decision about significance levels (e.g. a 10% or 5% probability of Type 1 error – i.e. incorrectly 
rejecting a true null hypothesis) and confidence intervals selected by the researcher (e.g. a 90 or 95% 
probability of the true value lying within the interval). 
 Methodology and results. For experimental evidence, the Bradford Hill features or characteristics of 
causal associations [1] provide an excellent starting point for investigating causality. These include: 
temporality, strength of the association, consistency of the observations, biological plausibility of the 
effect and evidence for recovery following diminution of the agent suspected of causing stress.  
      Within each experimental study HSAC would also have regard to the following: 
Methodology. For given data sources the methods used should have a sound scientific basis and 
should be fully described, capable of repetition and appropriate to the aims of the study.  The 
reproducibility of the method should be tested by statistical examination of the replicates where the 
variability should ideally be low. The risks of bias in data collection should have been considered 
in the study design, and the efforts made to minimise any recognisable bias should be declared. 
There should be evidence of sound laboratory procedure, such as the use of controls and analytical 
blanks. 
Results and interpretation. Results should be presented in a transparent way and should have 
appropriate statistical validity and power (for example, the data set should be of a suitable size, and 
appropriate confidence intervals and significance levels should be used). The caveat to any study is 
‘under the experimental conditions described’, so it is important that the conditions are relevant to 
the problem under investigation. The interpretation of the data should consider potential sources of 
error in the study, and the extent to which these affect the degree of uncertainty assigned to the 
findings and conclusions. The null and alternative hypotheses should be carefully constructed so 
that the study gives robust findings, allowing researchers to be confident about their result. 
 Completeness. A study should be sufficiently complete to enable third parties to review it and arrive at 
an independent interpretation of its findings, which may or may not coincide with that of the original 
authors. As already noted, the authors should themselves attempt to identify uncertainties and 
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weaknesses in a given study, though it may not be easy (or even possible) to be comprehensive in this 
respect (see Sections 4 and 5). 
 Independent review. The source of a study, and the likelihood of bias, are important considerations 
when assessing the quality of evidence (see also Section 5). Peer review (that is, review of a study by 
those regarded as having expertise in the field) is critical in this respect, even if it is an imperfect 
process.  Greater confidence is also gained as other independent scientists replicate the original findings.  
 Accessibility. Studies should be published or available in archival form in the public domain, so that the 
evidence can be readily examined. Even if they are not freely available, the costs of access to cited 
studies should not be prohibitive. Ideally, the raw data on which the study is based should also be 
available in a comprehensible form, so that its use can be assessed by others. 
A number of formalised approaches, including, for example, the ‘Klimisch criteria’ and Harris et al. [2, 3], 
suggest further attributes of what might be considered ‘high quality evidence’, and these can be incorporated 
into  a ‘weight of evidence’ approach [4] and systematic review. HSAC’s remit means that it may be called 
upon to assess and report on a wide range of areas and potential hazards, and the specific approach used 
needs to be selected on a case-by-case basis. HSAC seeks to ensure that its recommendations are fully and 
transparently described. 
It is important to be aware of the limitations of criteria such as those described above. Even studies that ‘tick 
all the boxes’ may, for example, be the subject of unconscious bias or ‘groupthink’; research questions and 
design may be influenced by experimenters’ prior beliefs, or driven by particular fashions or pressures to 
publish. Researchers may form their conclusions relatively quickly, using heuristics or ‘rules of thumb’ 
(quick decision-making devices that can be useful but can also lead to biased assessments of evidence) and 
when these approaches are applied they may or may not have a reasonable empirical basis [5]. Further, it is 
in the nature of certain forms of bias that they seem normal and unbiased to those who hold them. HSAC 
considers it important, therefore, always to reflect on research questions and assumptions when considering 
scientific evidence, and to ask, for example, 'how has the study been framed?', and 'what might have been 
missed?' It is just as important for HSAC itself to reflect on assumptions and possible biases in its own 
evaluation of the evidence - a process that is facilitated by the diversity of the Committee. 
 
4. The wider context 
Criteria for assessing the quality of evidence can be surprisingly difficult to distinguish from those that 
individuals and groups deploy, consciously or not, in judging how much credence to attach to evidence in a 
particular case. The difficulty lies in identifying a benchmark from which to determine whether evidence is 
‘sound’, in some wholly impartial, objective sense. In assessing the available evidence, and offering an 
opinion, HSAC is conscious that the science alone, while of fundamental importance, is unlikely to settle 
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issues of deep controversy. Rather, those presented with new evidence (scientists and advisors, as well as 
pressure groups, publics and decision makers) tend to be influenced by: 
• Trust in the source of the evidence. Important considerations are whether the evidence comes from an 
individual or institution seen to have authority from the recipient’s perspective and whether the source has 
a known, explicit or inferred bias. Obvious interests in the issue at hand can reduce the trustworthiness of 
evidence (‘they would say that wouldn’t they?’). Conversely, evidence that takes an unpredictable or 
unexpected line can sometimes be persuasive.  
• Defensibility. Recipients of evidence form views about whether it has been arrived at in a defensible way, 
and there is clearly overlap here with the standard, scientific criteria for ‘good’ evidence (Section 3). The 
wider point is that in matters of controversy, the quality of the evidence is itself likely to be a matter for 
dispute, because this becomes part of the process of questioning unwelcome findings. Assumptions, 
judgements and biases (which are always, and necessarily, present, sometimes hidden behind claims about 
‘objectivity’) are likely to be exposed and questioned. 
• Conformity to the recipient’s ‘worldview’. Worldviews may include beliefs about nature (for example, 
whether natural systems are fragile or robust) and positive/negative feelings about particular ‘risky’ 
activities; they may be shared within groups, communities and cultures [6, 7]. Even for the most ‘objective’ 
of recipients, evidence is likely to be filtered through a worldview. 
• Framing. Evidence may be more persuasive if it relates to a meaningful framing of the problem from the 
recipient’s perspective [8]. Individuals may be unimpressed by evidence suggesting that substance X is 'safe' 
if the risk in question is not what really bothers them about that substance (for example, if reassurances are 
based on potential harms to human health, but concerns are with possible effects in the wider environment). 
Alternatively, they are likely to seize upon evidence exonerating X, if X is a substance whose use they want 
to promote.  Even high quality evidence, according to criteria such as those in Section 3, will make little 
difference if it relates to an issue that is not, in fact, the primary issue of concern.  
HSAC needs to be aware of these wider considerations, in addition to ‘purely’ scientific matters, when 
reviewing the available evidence and will aim to reflect them when presenting an opinion (Figure 1. and 
S.I.). HSAC's view is that awareness of context and different perspectives will enhance both the quality of its 
own deliberations and the utility of its opinions for decision-makers. 
5. Towards a transparent assessment 
HSAC addresses different kinds of questions, for which the evidence varies in terms of type, quality and 
amount. The Committee needs, therefore, to be flexible in its specific approach when weighing the evidence 
and arriving at an opinion (examples of published HSAC opinions are provided in S.I.). Criteria of the kind 
outlined in Section 3 can be applied as appropriate to the scientific evidence but the body of evidence as a 
whole needs also to be considered, and HSAC will take account of important, wider questions such as those 
of problem framing. As noted in Section 3, HSAC also reflects on its own perspectives (assisted by the 
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diversity of its membership) and on the wider context within which the problem has been framed. The 
Committee’s intention, in adopting this rounded approach (Figure 1.), is to reach opinions that are robust, 
relevant and defensible. HSAC also considers how it might best reflect the overall strength of any given 
assessment and communicate the degree of confidence in its opinion. Quantitative measures, while attractive 
in some senses, can be open to misinterpretation, but a number of useful systems exist for indicating levels of 
confidence in a qualitative way [9-11]. HSAC will adopt (and adapt) one or more of these systems, as 
appropriate to the case in hand, when presenting its conclusions. 
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Figure 1. HSAC workflow 
 
  
